Abstract
The ability of imidazole and triazole agonists to be recognized at the histamine H2-receptor and to activate it is evaluated by simulating the events leading to the biological response by means of ab initio quantum chemical methods. Results reveal a shift in the tautomeric preference upon deprotonation (or neutralization). The neutralization of the monocationic agonist changes the proton affinities of the heterocycle ring nitrogens. Such change triggers the proton relay system. A quantitative description of the H2-agonist potency is provided by the energetics of both sequential proton transfer processes. The relevance of other factors, such as affinity, in modulating the agonist activity is discussed.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.